Giuseppe Procopio

Giuseppe Procopio: Results of the prospective multicenter Cassiope trial in renal cell carcinoma

Giuseppe Procopio, Director of the Genitourinary cancer Unit at National Cancer Institute Foundation, shared on X:

“Happy to share the results of the prospective multicenter Cassiope trial in mRCC.”

A prospective noninterventional real-world study of cabozantinib in pretreated patients with advanced renal cell carcinoma refractory to vascular endothelial growth factor-targeted therapy (CASSIOPE).

Authors: Michael Staehler, Umberto Basso, Jean-Christophe Eymard, Philippe Barthelemy, Pierre Bigot, Mathieu Laramas, Michael Rink, Cristina Suarez, Aline Guillot, Jens Bedke, Paul Hamberg, Rocco De Vivo, Pablo Gajate, Martín Lázaro-Quintela, Priti Rastogi, Valérie Perrot, Bryan Qvick, Pascale Dutailly, Elena Verzoni, Giuseppe Procopio

Giuseppe Procopio

Aline Guillot Bryan Qvick cancer Cassiope trial Cristina Suárez Elena Verzoni Giuseppe Procopio Jean-Christophe Eymard Jens Bedke Martín Lázaro-Quintela Mathieu Laramas Michael Rink Michael Staehler mRCC OncoDaily Oncology Pablo Gajate Pascale Dutailly Paul Hamberg Philippe Barthélémy Pierre Bigot Priti Rastogi renal cell carcinoma Rocco De Vivo Umberto Basso Valérie Perrot